The effect of continuous combined HRT on glucose homeostasis and plasma lipids: A placebo-controlled study in postmenopausal women with type 2 diabetes

Maturitas

Volumn 53, Issue 4, 2006, Pages 430-438

  Thunell, Louise ^a   Andersson, Björn ^a   Glassell, Marie ^a   Mattsson, Lars Åke ^a  

^a NONE

Author keywords

Glucose homeostasis; Hormone replacement therapy; Lipids; PAI 1; Postmenopausal women; Type 2 diabetes

Indexed keywords

C PEPTIDE; ESTRADIOL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; LIPOPROTEIN; NORETHISTERONE ACETATE; PLASMINOGEN ACTIVATOR INHIBITOR; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HORMONAL THERAPY; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TIME;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERANDROGENISM; LIPID METABOLISM; MIDDLE AGED; NORETHINDRONE; SEX HORMONE-BINDING GLOBULIN; STATISTICS, NONPARAMETRIC;

EID: 33644635448     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.07.008     Document Type: Article

References (41)

1. E. Barrett-Connor, and D.L. Wingard Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study Am J Epidemiol 118 4 1983 489 496
2. M.J. Stampfer, G.A. Colditz, and W.C. Willett Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study N Engl J Med 325 11 1991 756 762
3. M. Falkeborn, I. Persson, and H.O. Adami The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement Br J Obstet Gynaecol 99 10 1992 821 828
4. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94(6):646-50.
5. J.E. Rossouw, G.L. Anderson, and R.L. Prentice Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333 Jul 17
6. S. Hulley, D. Grady, and T. Bush Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group JAMA 280 7 1998 605 613
7. L. Lapidus, G. Lindstedt, P.A. Lundberg, C. Bengtsson, and T. Gredmark Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women Clin Chem 32 1 1986 146 152 Pt 1
8. G. Lindstedt, P.A. Lundberg, L. Lapidus, H. Lundgren, C. Bengtsson, and P. Bjorntorp Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden Diabetes 40 1 1991 123 128
9. S.M. Haffner, R.A. Valdez, P.A. Morales, H.P. Hazuda, and M.P. Stern Decreased sex hormone-binding globulin predicts noninsulin-dependent diabetes mellitus in women but not in men J Clin Endocrinol Metab 77 1 1993 56 60
10. B. Andersson, P. Marin, L. Lissner, A. Vermeulen, and P. Bjorntorp Testosterone concentrations in women and men with NIDDM Diabetes Care 17 5 1994 405 411
11. B. Andersson, L.A. Mattsson, and L. Hahn Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 82 2 1997 638 643
12. L. Hahn, L.A. Mattsson, B. Andersson, and L. Tengborn The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus Blood Coagul Fibrinolysis 10 2 1999 81 86
13. H.E. Brussaard, J.A. Gevers Leuven, M. Frolich, C. Kluft, and H.M. Krans Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM Diabetologia 40 7 1997 843 849
14. H.E. Brussaard, J.A. Gevers Leuven, and C. Kluft Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus Arterioscler Thromb Vasc Biol 17 2 1997 324 330
15. D. Grady, T. Gebretsadik, K. Kerlikowske, V. Ernster, and D. Petitti Hormone replacement therapy and endometrial cancer risk: a meta-analysis Obstet Gynecol 85 2 1995 304 313
16. B. Szekacs, Z. Vajo, and S. Varbiro Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension Bjog 107 8 2000 1017 1021
17. D. Owens, P.B. Collins, A. Johnson, and G.H. Tomkin Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate Diabet Med 17 4 2000 308 315
18. J. McKenzie, A.J. Jaap, and S. Gallacher Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk? Clin Endocrinol (Oxf) 59 6 2003 682 689
19. S.H. Lilley, J.M. Spivey, S. Vadlamudi, J. Otvos, D.M. Cummings, and H. Barakat Lipid and lipoprotein responses to oral combined hormone replacement therapy in normolipemic obese women with controlled type 2 diabetes mellitus J Clin Pharmacol 38 12 1998 1107 1115
20. K. Samaras, C.S. Hayward, D. Sullivan, R.P. Kelly, and L.V. Campbell Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study Diabetes Care 22 9 1999 1401 1407
21. P. Manwaring, L. Morfis, T. Diamond, and L.G. Howes The effects of hormone replacement therapy on plasma lipids in type II diabetes Maturitas 34 3 2000 239 247
22. B. Andersson, and L.A. Mattsson The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM Acta Obstet Gynecol Scand 78 3 1999 260 261
23. H. Mosnier-Pudar, B. Faguer, T.T. Guyenne, and G. Tchobroutsky Effects of deprivation and replacement by percutaneous 17 beta estradiol and oral progesterone on blood pressure and metabolic parameters in menopause patients with non-insulin-dependent diabetes Arch Mal Coeur Vaiss 84 8 1991 1111 1115
24. World Health Organisation, Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus, Geneva: World Health Organisation, 1999.
25. H. Skoldborn, B. Arvidsson, and M. Andersson A new whole body monitoring laboratory Acta Radiol Suppl 313 1972 233 241
26. Forbes GB, Gallup J, Hursh JB. Science, vol. 133, 1961: estimation of total body fat from potassium-40 content. Nutr Rev 1991;49(4):109-11.
27. S.M. Haffner, J.F. Dunn, and M.S. Katz Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women Metabolism 41 3 1992 278 284
28. K.A. Matthews, E. Meilahn, L.H. Kuller, S.F. Kelsey, A.W. Caggiula, and R.R. Wing Menopause and risk factors for coronary heart disease N Engl J Med 321 10 1989 641 646
29. P.J. Manning, A. Allum, S. Jones, W.H. Sutherland, and S.M. Williams The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial Arch Intern Med 161 14 2001 1772 1776
30. A.M. Scanu, and G.M. Fless Lipoprotein (a). Heterogeneity and biological relevance J Clin Invest 85 6 1990 1709 1715
31. I. Juhan-Vague, C. Roul, M.C. Alessi, J.P. Ardissone, M. Heim, and P. Vague Increased plasminogen activator inhibitor activity in non insulin dependent diabetic patients - relationship with plasma insulin Thromb Haemost 61 3 1989 370 373
32. C. Borgfeldt, C. Li, and G. Samsioe Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1 Climacteric 7 1 2004 78 85
33. J.E. Manson, E.B. Rimm, and G.A. Colditz A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin- dependent diabetes mellitus Ann Epidemiol 2 5 1992 665 673
34. K.L. Margolis, D.E. Bonds, and R.J. Rodabough Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial Diabetologia 47 7 2004 1175 1187
35. A.M. Kanaya, D. Herrington, and E. Vittinghoff Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial Ann Intern Med 138 1 2003 1 9
36. A.R. Scott, P. Dhindsa, J. Forsyth, and P. Mansell Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes Diabetes Obes Metab 6 1 2004 16 22
37. D. Crook, I.F. Godsland, J. Hull, and J.C. Stevenson Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up Br J Obstet Gynaecol 104 3 1997 298 304
38. N.D. Stojanovic, P. Kwong, and D.J. Byrne The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: a pilot study Angiology 54 4 2003 391 399
39. I.F. Godsland Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974 to 2000 Fertil Steril 75 5 2001 898 915
40. G.M. Rosano, C. Vitale, A. Silvestri, and M. Fini Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection Maturitas 46 Suppl. 1 2003 17 29
41. N.A. Manassiev, I.F. Godsland, D. Crook, A.J. Proudler, M.I. Whitehead, and J.C. Stevenson Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women Maturitas 42 3 2002 233 242